Technical Articles

A step-by-step SOP for ActRIIA kinase inhibitor screening: enzyme concentration titration, Z' factor acceptance thresholds, positive control LDN-193189 dilution design, luminescence readout linearity and the four most common failure nodes with troubl

A systematic review of ActRIIA: extracellular ligand-binding domain, constitutively active intracellular kinase, ALK4 recruitment and SMAD2/3 phosphorylation. Covers physiological contexts from FSH rhythm in the pituitary to osteoclast-osteoblast bal

ActRIIA (ACVR2A) differs from its famous sibling ActRIIB by one letter, yet its fate diverged: outside the muscle spotlight it grew into a main line in bone metabolism and reproductive endocrine research. This article dissects the dual identity of Ac

Picture the ActRIIB kinase assay as a brake light: the brighter the enzyme activity, the tighter the muscle brake. This article walks through the complete journey of an inhibitor from addition to readout in four acts.

A tool-oriented guide to ActRIIB kinase inhibitor screening: ATP and enzyme concentration settings, control systems and Z' factor interpretation, luminescence interference checks and IC50 fitting considerations.

ActRIIB is the type I receptor kinase for myostatin and activin signaling, writing the 'grow less muscle' instruction into the nucleus. This review covers its receptor structure, signaling axis, disease associations and in vitro research tools.

A tool-oriented guide to FGFR4 binding experiments: the KLB co-receptor prerequisite, D2-D3 integrity quality control, SPR/ELISA parameter settings and troubleshooting paths for three types of data anomalies.

Among the four FGFR family members, FGFR4 alone resides in the liver and binds the KLB co-receptor. From an industry perspective, this article dissects the FGF19 axis, its association with hepatocellular carcinoma and the design logic of selective in

The FGFR4 door opens only when both keys—FGF19 and KLB—are inserted at the same time. This article walks through the four-step assembly of the FGF19-FGFR4-KLB ternary complex and the full process of signal entry.

TLR4 signaling branches at the TIR domain into MyD88-dependent and TRIF-dependent pathways, driving NF-κB/MAPK and IRF3/interferon responses respectively. This review systematically covers pathway hierarchy, readout indicators and experimental consid